This study, based on a US administrative claims database, examined prescription patterns, comorbidities and flares determinants in a very large population of gout patients. In line with current ...
Notably, 39% of patients did not receive any prescription medication for gout. Patients with comorbidities were significantly more likely to receive anti-gout prescriptions. During an acute ...
Sweden’s Sobi has kicked off a rolling biologics license application in the US for SEL-212, vying to become a new option for patients with refractory chronic gout that doesn’t respond to ...